Package details
Original BDPM fields are shown in French.
- Official name
- KALETRA (80 mg + 20 mg)/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 2 flacon(s) multidose(s) jaune(brun) polytéréphtalate (PET) de 60 ml avec 2 seringue(s) pour administration orale 2ml
- Marketing authorisation holder
- ABBVIE DEUTSCHLAND (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jan 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69474926CIP73011729CIP133400930117293Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LOPINAVIRsolution | 80 mg · 1 ml | SA |
| RITONAVIRsolution | 20 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.